HK Stock Market Move | AVICHINA (02357) fell more than 4% in the afternoon, with several of its subsidiaries releasing first quarter results. AVICOPTER PLC's non-GAAP net profit fell by more than 90%.
AVIC Aircraft (02357) fell more than 4% in the afternoon, as of the time of writing, it fell by 4.46% to 3.43 Hong Kong dollars, with a turnover of 57.43 million Hong Kong dollars.
AVICHINA (02357) fell more than 4% in the afternoon, closing down 4.46% at HK$3.43, with a trading volume of HK$57.4384 million.
On the news front, several listed companies under AVICHINA released their first quarter results. During the period, AVICOPTER PLC's non-GAAP net profit decreased by 92.01% to approximately 152.485 million yuan; Jonhon Optronic Technology's net profit attributable to shareholders decreased by 37.75% to 3.98 billion yuan; Jiangxi Hongdu Aviation Industry achieved a net profit attributable to shareholders of 6.2612 million yuan, turning a loss into a profit; AVIC Airborne Systems' net profit attributable to shareholders increased by 78.48% to 1.8 billion yuan.
Related Articles

HK Stock Market Move | EAST BUY (01797) rose more than 5% in the closing session. Four major anchors resigned on the same day. The new management team continues to promote "decentralization".

Guosheng: The banking industry's revenue and profit have both improved compared to the previous year over the past 25 years. Two main themes are highly recommended.

A-share market review: Shanghai Composite Index fell by 0.19%, leading companies' performance impressive! Igniting the pharmaceutical industry race.
HK Stock Market Move | EAST BUY (01797) rose more than 5% in the closing session. Four major anchors resigned on the same day. The new management team continues to promote "decentralization".

Guosheng: The banking industry's revenue and profit have both improved compared to the previous year over the past 25 years. Two main themes are highly recommended.

A-share market review: Shanghai Composite Index fell by 0.19%, leading companies' performance impressive! Igniting the pharmaceutical industry race.






